CUSP9
CUSP9
CUSP9 (pronounced: /kʌsp naɪn/), also known as Coordinated Undermining of Survival Paths by 9 Repurposed Drugs, is a treatment protocol for glioblastoma, a type of brain tumor. The term "CUSP9" is derived from the initial letters of the phrase "Coordinated Undermining of Survival Paths by 9 Repurposed Drugs".
Etymology
The term "CUSP9" was coined by a group of researchers who developed the treatment protocol. The word "cusp" is derived from the Latin word "cuspis", which means "point" or "apex". The number "9" refers to the nine repurposed drugs used in the treatment protocol.
Treatment Protocol
The CUSP9 treatment protocol involves the use of nine repurposed drugs, including aprepitant, celecoxib, disulfiram, itraconazole, ritonavir, sertraline, minocycline, captopril, and tadalafil. These drugs are used in combination with temozolomide, a standard chemotherapy drug for glioblastoma.
Related Terms
- Glioblastoma: A type of brain tumor that the CUSP9 treatment protocol is designed to treat.
- Repurposed drugs: Drugs that are used for a different purpose than they were originally intended for. In the case of CUSP9, nine repurposed drugs are used in the treatment protocol.
- Temozolomide: A standard chemotherapy drug for glioblastoma that is used in combination with the nine repurposed drugs in the CUSP9 treatment protocol.
External links
- Medical encyclopedia article on CUSP9
- Wikipedia's article - CUSP9
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski